BNET Industries
Last Fiscal Year Sales:$35.9B
- Public
- DE
Dow Jones Description
Bayer is a global enterprise with core competencies in the fields of health care, nutrition and high-tech materials. Our products and services are designed to benefit people and improve their quality of life. At the same time we want to create value through innovation, growth and improved earning power. We already successfully reorganized the Bayer Group and further streamlined our portfolio to create a new Bayer that is focused on its corporate strengths, its customers and the markets of the future. To help us achieve this goal, we then carried out a strategic realignment in order to concentrate in future on three high-potential, agile subgroups with largely independent operations: HealthCare, CropScience and MaterialScience, supported by three service companies. Our operating companies give us the access we need to the growth markets of the future. As an inventor company, we plan to continue setting trends in research-intensive areas. Innovations are the foundation for our competitiveness and our corporate growth, and thus for our success in the future. We believe our technical and commercial expertise entails a duty to contribute to sustainable development ? a principle we wholeheartedly endorse, mindful of its social, ethical and environmental elements. In awareness of our responsibilities as a corporate citizen, we define economy, ecology and social commitment as objectives of equal rank. We seek to retain society?s confidence through performance, flexibility and open communication as we work in pursuit of our overriding corporate goals: to steadily create corporate value and generate high value-added for the benefit of our stockholders, our employees and the community in every country in which we operate.
Director, Finance
Klaus KuhnNumber of Employees 122,100
Peer Companies
NAICS Code Plastics Material and Resin Manufacturing: 325211
Recent Events
-
Endo Pharma Gets a Setback
-
Bayers Betaferon approved in China for Treatment of Multiple Sclerosis
-
UPDATE 3-US FDA declines to approve Endo testosterone drug
-
UPDATE 1-Futuragene signs licence deal with Bayer CropScience
-
Bayer and United Nations Environment Programme Launch 19th Annual International Children's...
-
Bayer Consumer Care Launches CitracalR Calcium Plus Heart Health
-
German drug, chemical company Bayer's Q3 net income falls 10 per cent
-
Bayer, US Onyx launch phase III trial of Nexavar in patients with non-responsive thyroid cancer
-
BRIEF-Credit Suisse raises targets on European pharma cos
-
Bayer accused of hiding Yaz contraceptive risk
-
Bayer downgraded to neutral from buy at UBS
-
Abbott Laboratories to acquire Solvay Pharmaceuticals
-
Bayer's contested kidney cancer drug shows benefit
-
Bayer names new CEO
-
Bayer Introduces CONTOUR USB - The First Blood Glucose Meter With Unique Plug & Play...
-
Bayer's next CEO has a year to prepare Today
News & Analysis
Filter by
bayer ag and stock - All News and Analysis
Postbank to replace Schering in German blue-chip DAX stock index
FRANKFURT AFP — Postbank, the banking arm of German postal and logistics giant Deutsche Post, is to replace pharmaceuticals specialist Schering in the Frankfurt stock exchange's blue-chip DAX 30 stock index, stock market operator Deutsche Boerse announced. The switch would take place on September 18, Deutsche Boerse said in a...
European stocks gain in early trade
LONDON AFP — European stock markets have been lifted by the mining and auto sectors, and in the wake of gains made by Wall Street overnight. London's FTSE 100 index of leading shares rose 0.30 percent to 5,875.00 points, Frankfurt's DAX 30 index climbed 0.72 percent to 5,656.17 points...
Amexdrug Launches New Product Line: AXRX, SLXP, NUVO, BAY, GTIV.
M2 PRESSWIRE-6 January 2006-SessionsIR.com: Amexdrug Launches New Product Line: AXRX, SLXP, NUVO, BAY, GTIVC1994-2006 M2 COMMUNICATIONS LTD RDATE:06012006 Stocks in the News: Amexdrug Corporation (OTC: AXRX), Salix Pharmaceuticals Limited. (NASDAQ: SLXP), Nuvelo Incorporated (NASDAQ: NUVO), Bayer AG (NYSE: BAY), Gentiva...
Nuvelo (NUVO) SqueezeTrigger Price Is $8.07. Short Sellers Are Down Approximately $8.5 Million After Company Signs Deal with Bayer HealthCare.
M2 PRESSWIRE-5 January 2006-BUYINS.NET: Nuvelo NUVO SqueezeTrigger Price Is $8.07. Short Sellers Are Down Approximately $8.5 Million After Company Signs Deal with Bayer HealthCare.C1994-2006 M2 COMMUNICATIONS LTD RDATE:05012006 BUYINS.NET, www.buyins.net, announced today that the 2.08 million shares declared short on...
Stocks on the Rise.
M2 PRESSWIRE-27 April 2005-WallStreetGrapevine: Stocks on the RiseC1994-2005 M2 COMMUNICATIONS LTD RDATE:27042005 Wall Street, NYC-- Today, wallstreetgrapevine.com, named; Bio Matrix Scientific Group Inc. (BMXG.PK), Astralis Ltd. (ASTR.OB), ONYX Pharmaceuticals Inc. (Nasdaq NM: ONXX), and Protein Design Labs Inc. (Nasdaq NM:...
European stocks struggle out the blocks
LONDON AFP ? European stock markets began the week downbeat in the wake of a poor finish on Wall Street, with London the only riser in trading, helped by a strong showing from financials, dealers said. The British FTSE 100 index inched 0.03 percent higher to 4,340.40 points, while...
Stock Market's Furry Friends: PTNW, PETS, PETC, ANML, CENT.
M2 PRESSWIRE-3 May 2004-InvestSource Inc.: Stock Market's Furry Friends: PTNW, PETS, PETC, ANML, CENTC1994-2004 M2 COMMUNICATIONS LTD RDATE:05032004 Petcare Television Network Incorporated (OTCBB: PTNW) has a green alert on it as the company was up .04 at .89 during Friday's ...
Bayer stock rockets on Baycol ruling. (News).
SHARES OF Bayer AG shot up after a Corpus Christi, Tex., jury ruled that US subsidiary Bayer Corp. is not liable in a $560 million suit brought against the company, charging that it ignored research linking its Baycol cholesterol lowering drug to d SHARES...
Bayer's stock declines on disappointing results. (News: Europe).(Brief Article)
BAYER'S SHARE price on the Frankfurt stock exchange slumped to a 12-month low of [euro]20 ($19) last week after the company reported unexpectedly poor profits during the second quarter. The company has struggled to improve the performance of i ...
Bidding without boundaries
Kroll, Karen M Industry Week 04-01-2002 Bidding without boundaries Byline: Kroll, Karen M Volume: 251 Number: 3 ISSN: 00390895 Publication Date: 04-01-2002 Page: 73 Type: Periodical Language: English GLOBALIZATION HEADNOTE PUBLIC MANUFACTURING COMPANIES WILL INEED TO REACH OUT TO A WORLD OF INVESTORS AS STOCK EXCHANGES GO...
- 1
- 2
Decision Makers
| Name (plus bio) | Position |
|---|---|
| Klaus Kuhn | Director, Finance |
| Richard Pott | Director, Strategy and Human Resources |
| Wolfgang Plischke | Director, Innovation, Technology and Environment |
| Hartmut Klusik | Head, Product Supply |
| Gary S Balkema | Executive Committee Member |
Board of Directors
| Name (plus bio) | Position |
|---|---|
| Arthur J Higgins | Chairman, HealthCare |
| Werner Wenning | Executive Chairman |
| Klaus Kleinfeld | Board of Directors |
| Paul Achleitner | Board of Directors |
| Organization | Position | Status |
|---|---|---|
| Bayer AG | Director, Finance | Current |
| University of South Carolina | MBA | Former |
| Organization | Position | Status |
|---|---|---|
| Bayer AG | Director, Strategy and Human Resources | Current |
| University of Cologne | doctorate in physics | Former |
| Organization | Position | Status |
|---|---|---|
| Bayer AG | Director, Innovation, Technology and Environment | Current |
| Bayer HealthCare AG | Manager | Current |
| Bayer HealthCare AG | Board of Directors | Current |
| Organization | Position | Status |
|---|---|---|
| Bayer AG | Head, Product Supply | Current |
| Organization | Position | Status |
|---|---|---|
| Bayer AG | Chairman, HealthCare | Current |
| Enzon Pharmaceuticals, Inc. | CEO | Former |
| Pharmaceutical Research and Manufacturers of America | member | Former |
| Bayer HealthCare, Animal Health Division | Chairman | Former |
| Enzon Pharmaceuticals, Inc. | Chairman | Former |
| Organization | Position | Status |
|---|---|---|
| Bayer AG | Executive Chairman | Current |
| Henkel AG & Co. KGaA | Supervisory Board | Current |
Klaus Kleinfeld is president and chief executive officer of Alcoa. He joined the company in 2007 as president and chief operating officer and seven months later assumed CEO responsibilities. He has served on Alcoa's board of directors since 2003. Alcoa is a world leader in the production and management of a very sustainable product: aluminum. Nearly 75% of the aluminum ever produced since 1888 is still in use today. The company has been a technology leader since its beginning, providing more than 90% of the aluminum alloys used in aircraft and space flight; helping making automobiles lighter, without compromising safety or performance; manufacturing sheet that created the ultimate recyclable container, the aluminum beverage can; and providing building and construction industry materials that help further the green building movement. In addition, to serving customers in these markets, Alcoa also markets wheels, fastening systems, precision and investment castings, and building systems. The company has 97,000 employees in 34 countries. Before coming to Alcoa, Mr. Kleinfeld had a 20-year career with Siemens, the global electronics and industrial conglomerate, based in the U.S. and Germany, where he served as chief executive officer of Siemens AG starting in 2005. During his tenure, Mr. Kleinfeld presided over a dramatic transformation of the company, reshaping the company's portfolio around three high growth areas, resulting in increase of revenues and market capitalization nearly doubled. Prior to his service on the Managing Board of Siemens AG, Mr. Kleinfeld was President and Chief Executive Officer of Siemens Corporation, its U.S. arm and the company's largest region. In addition to serving on Alcoa's board, he is a member of the board of Bayer AG. On the personal front, Mr. Kleinfeld was born in Bremen, Germany and educated at the University of Goettingen and University of Wuerzburg, both in Germany. He holds a Ph.D in strategic management and master's degree in business administration. In his leisure time, he enjoys skiing, tennis, the arts and is a marathon runner. Mr. Kleinfeld resides in New York with his wife and children.
| Organization | Position | Status |
|---|---|---|
| Alcoa, Inc. | President & Chief Executive Officer | Current |
| Bayer AG | Board of Directors | Current |
| Alcoa, Inc. | Board of Directors | Current |
| Siemens AG | President & CEO | Former |
| Siemens Corporation | Chief Executive Officer | Former |
| Alcoa, Inc. | Chief Operating Officer | Former |
| Siemens Corporation | Chief Operating Officer | Former |
| Siemens AG | Chief Operations Officer, U.S. | Former |
| Siemens AG | Executive Vice President | Former |
| Siemens AG | Audit Committee Principal | Former |
| Citigroup Inc. | Board of Directors | Former |
| Siemens AG | Board of Directors | Former |
| Siemens Corporation | member | Former |
| Organization | Position | Status |
|---|---|---|
| Allianz SE | Executive Director, Finance | Current |
| Bayer AG | Board of Directors | Current |
| Goldman, Sachs & Co. | Vice President, Mergers & Acquisitions | Former |
| Bain & Company | Manager, Strategy Consulting | Former |
| Organization | Position | Status |
|---|---|---|
| Bayer AG | Executive Committee Member | Current |
| Bayer HealthCare, Animal Health Division | President, Worldwide Bayer Consumer Care Division | Former |
| Fairleigh Dickinson University | master of business administration degree | Former |
Executive News
-
Report from Europe: U.S. Close vs. China Rebound
-
Alcoa Named Component of Dow Jones Sustainability Index for Eighth Consecutive Year
-
Alcoa says global aluminium demand to fall 5.5 pct -Bloomberg
-
Siemens To Settle Bribery Charges with Three Former Execs
-
Siemens poised to settle with ex-managers
-
UPDATE 1-Siemens poised to settle with ex-managers
-
UPDATE 1-Siemens poised to settle with ex-managers
-
Bayer AG (BAY.F) May Be Ready for Deals After Lost Intervet Bid
-
Inventories May Temper Aluminum Rally
Industry Transcripts by Seeking Alpha
-
Rentech, Inc. F4Q09 (Qtr End 09/30/09) Earnings Call Transcript
on Dec 15, 2009about RTK
-
Esterline Technologies Corporation F4Q09 (Qtr End 10/30/09) Earnings Call Transcript
on Dec 10, 2009about ESL
-
FuelCell Energy Inc. F4Q09 (Qtr End 10/31/09) Earnings Call Transcript
on Dec 10, 2009about FCEL
-
Greif Inc. F4Q09 (Qtr End 10/31/09) Earnings Call Transcript
on Dec 10, 2009about GEF
-
Pall Corporation F1Q10 (Qtr End 10/31/09) Earnings Call Transcript
on Dec 10, 2009about PLL
Glass Door
Bayer AG
IndustryTop Rated
- Google Offers Free Downloads of a Million Books 11 votes
- InsideView Disrupts Legacy Business Info Publishers Like Hoover's 9 votes
- Mobile is the New Mass Medium, For Better or Worse 8 votes
- As Income Mobility Falls, American Dream Fades 7 votes
- E-Book Publisher Smashwords Partners with Barnes & Noble 6 votes
